Stifel Financial
MBII

Stifel Financial’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Stifel Financial’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,866
Closed -$12K – 3549
2021
Q4 		$12K Buy
+16,866
New +$13.6K ﹤0.01% 3355
2015
Q2 		– Sell
-14,625
Closed -$57K – 2448
2015
Q1 		$57K Buy
14,625
+625
+4% +$2.31K ﹤0.01% 2235
2014
Q4 		$51K Buy
+14,000
New +$37.1K ﹤0.01% 2226

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stifel Financial's MBII Position: Q1 2022 in Review

Stifel Financial sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 16,866 shares — an estimated $12K sold.

Stifel Financial first reported a position in MBII in Q4 2014 and held it in 3 quarters. The position peaked at $57K in Q1 2015. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Stifel Financial reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Stifel Financial sold 16,866 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $12K.
  • Stifel Financial first reported a position in Marrone Bio Innovations, Inc. in Q4 2014 and held it in 3 quarters.
  • Stifel Financial's Marrone Bio Innovations, Inc. position peaked at $57K in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Stifel Financial's 13F filing for Q1 2022, filed 13 May 2022.